Logo
x

Search

Subscribe Now

Basilea Pharmaceutica

Basilea’s Zevtera Receives the US FDA’s Approval for Staphylococcus aureus Bloodstream Infections

Basilea’s Zevtera Receives the US FDA’s Approval for Staphylococcus aureus Bloodstream Infections

  • April 3, 2024
Basilea Pharmaceutica Acquires Spexis’ Preclinical Antibiotics Program for $2.34M

Basilea Pharmaceutica Acquires Spexis’ Preclinical Antibiotics Program for $2.34M

  • January 15, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.